Skip to main content

A novel air filtration delivery system improves seasonal allergic rhinitis

Buy Article:

$39.50 plus tax (Refund Policy)


Twenty percent of the United States population has respiratory allergies. The preferable treatment for allergies is avoidance. Bedrooms offer the best opportunity for allergen avoidance. Most previous studies of air filtration only measured the effect on allergen particle counts, but few have addressed the clinical efficacy. This study measured the effects of a novel laminar flow air filtration device (PureNight) on seasonal ragweed allergies. Seventy-seven percent of the subjects improved significantly on symptom scores, an average of 26% improvement in the morning and 24% in the evening. Daytime sleepiness and quality of life scores also improved significantly in all subjects. Tolerability was excellent. The PureNight device provided significant clinical improvement of allergic symptoms during ragweed hay fever season.

Document Type: Research Article

Publication date: 2006-01-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more